Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
dihydrolipoamide acetyltransferase
-
dihydrolipoyl acetyltransferase
-
acetyltransferase, lipoate
-
-
-
-
dihydrolipoate acetyltransferase
-
-
-
-
dihydrolipoic transacetylase
-
-
-
-
dihydrolipoyl acetyl transferase
-
-
dihydrolipoyl acetyltransferase
dihydrolipoyl acetyltransferase component E2
-
-
dihydrolipoyl transacetylase
dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial
-
-
lipoate acetyltransferase
-
-
-
-
lipoate transacetylase
-
-
-
-
lipoic acetyltransferase
-
-
-
-
lipoic acid acetyltransferase
-
-
-
-
lipoic transacetylase
-
-
-
-
lipoylacetyltransferase
-
-
-
-
myelin-proteolipid O-palmitoyltransferase
-
-
-
-
palmitoyl-CoA:myelin-proteolipid O-palmitoyltransferase
-
-
-
-
thioltransacetylase A
-
-
-
-
dihydrolipoyl acetyltransferase
-
-
-
-
dihydrolipoyl acetyltransferase
-
-
dihydrolipoyl acetyltransferase
-
glutathione-S-transferase fused to the inner lipoyl domain is used
dihydrolipoyl transacetylase
-
-
dihydrolipoyl transacetylase
-
is part of the human pyruvate dehydrogenase complex
E2
-
-
-
-
E2p
-
-
-
-
additional information
-
the enzyme forms the core unit E2 of the pyruvate dehydrogenase multienzyme complex binding the other components, i.e. pyruvate decarboxylase E1 and dihydrolipoyl dehydrogenase E3, tightly at its innerlipoyl or N-terminal lipoyl domain, respectively, composition overview
additional information
-
the enzyme forms the core unit E2 of the pyruvate dehydrogenase multienzyme complex binding the other components, i.e. pyruvate decarboxylase E1 and dihydrolipoyl dehydrogenase E3, tightly at its innerlipoyl or N-terminal lipoyl domain, respectively, composition overview
additional information
-
the enzyme is a subunit of the pyruvate dehydrogenase multienzyme complex, the enzyme forms the core unit E2 of the pyruvate dehydrogenase multienzyme complex binding the other components, i.e. pyruvate decarboxylase E1 and dihydrolipoyl dehydrogenase E3, tightly at its innerlipoyl or N-terminal lipoyl domain, respectively, composition overview
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
acetyl-CoA + enzyme N6-(dihydrolipoyl)lysine
CoA + enzyme N6-(S-acetyldihydrolipoyl)lysine
-
-
-
-
?
dihydrolipoamide + acetyl-CoA
S-acetyldihydrolipoamide + CoA
additional information
?
-
dihydrolipoamide + acetyl-CoA
S-acetyldihydrolipoamide + CoA
-
-
-
?
dihydrolipoamide + acetyl-CoA
S-acetyldihydrolipoamide + CoA
-
-
-
?
dihydrolipoamide + acetyl-CoA
S-acetyldihydrolipoamide + CoA
-
-
-
?
dihydrolipoamide + acetyl-CoA
S-acetyldihydrolipoamide + CoA
-
-
-
?
additional information
?
-
-
E2 plays a central role in organization, integrated chemical reactions, and regulation of the multienzyme complex, overview, binding and activation of regulatory enzyme pyruvate dehydrogenase kinase isozymes PDK1-4, the enzyme mediates Ca2+-activation of isozymes of pyruvate dehydrogenase phosphatase severalfold, and enhances the accessibility of the E1 substrate for the regulatory enzymes, and mediate feedback effector control by NADH and acetyl-CoA, and modifies the allosteric control, mechanism, overview
-
-
?
additional information
?
-
-
the enzyme E2 has an enormous impact on pyruvate dehydrogenase kinase PDK phosphorylation of the pyruvate dehydrogenase E1 component by acting as a mobile binding framework and in facilitating and mediating regulation of PDK activity, isozyme PDK2 interacts very weakly with L2 domain of E2, but much tighter with the recombinant dimeric glutathione S-transferase-L2 domain fusion protein, importance of bifunctional binding, interaction of PDK2 with the lipoyl domains L1 and L2 of E2, and the E3-binding protein L3, overview
-
-
?
additional information
?
-
-
the enzyme mediates Ca2+-activation of isozymes 1 of pyruvate dehydrogenase phosphatase by 10fold, and enhances the accessibility of the E1 substrate for the regulatory enzymes, and mediate feedback effector control by NADH and acetyl-CoA, and modifies the allosteric control, mechanism, overview
-
-
?
additional information
?
-
-
interactions are different with the different isoforms of the regulatory enzymes of the multienzyme complex, signal mechanism for stimulation, overview, enzyme forms the core of the pyruvate dehydrogenase multienzyme complex, the flexibly held outer domains of the enzyme show dynamic, E2 is responsible for effector-modified interactions with the complex' regulatory enzymes pyruvate dehydrogenase kinase PDK and pyruvate dehydrogenase phosphatase PDP, which exist in different isoforms, overview
-
-
?
additional information
?
-
-
the overall complex reaction is irreversible
-
-
?
additional information
?
-
-
in human pyruvate dehydrogenase complex the pyruvate dehydrogenase (E1) is bound to the E1-binding domain of dihydrolipoamide acetyltransferase (E2)
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
acetyl-CoA + enzyme N6-(dihydrolipoyl)lysine
CoA + enzyme N6-(S-acetyldihydrolipoyl)lysine
-
-
-
-
?
dihydrolipoamide + acetyl-CoA
S-acetyldihydrolipoamide + CoA
additional information
?
-
dihydrolipoamide + acetyl-CoA
S-acetyldihydrolipoamide + CoA
-
-
-
?
dihydrolipoamide + acetyl-CoA
S-acetyldihydrolipoamide + CoA
-
-
-
?
dihydrolipoamide + acetyl-CoA
S-acetyldihydrolipoamide + CoA
-
-
-
?
dihydrolipoamide + acetyl-CoA
S-acetyldihydrolipoamide + CoA
-
-
-
?
additional information
?
-
-
E2 plays a central role in organization, integrated chemical reactions, and regulation of the multienzyme complex, overview, binding and activation of regulatory enzyme pyruvate dehydrogenase kinase isozymes PDK1-4, the enzyme mediates Ca2+-activation of isozymes of pyruvate dehydrogenase phosphatase severalfold, and enhances the accessibility of the E1 substrate for the regulatory enzymes, and mediate feedback effector control by NADH and acetyl-CoA, and modifies the allosteric control, mechanism, overview
-
-
?
additional information
?
-
-
the enzyme E2 has an enormous impact on pyruvate dehydrogenase kinase PDK phosphorylation of the pyruvate dehydrogenase E1 component by acting as a mobile binding framework and in facilitating and mediating regulation of PDK activity, isozyme PDK2 interacts very weakly with L2 domain of E2, but much tighter with the recombinant dimeric glutathione S-transferase-L2 domain fusion protein, importance of bifunctional binding, interaction of PDK2 with the lipoyl domains L1 and L2 of E2, and the E3-binding protein L3, overview
-
-
?
additional information
?
-
-
the enzyme mediates Ca2+-activation of isozymes 1 of pyruvate dehydrogenase phosphatase by 10fold, and enhances the accessibility of the E1 substrate for the regulatory enzymes, and mediate feedback effector control by NADH and acetyl-CoA, and modifies the allosteric control, mechanism, overview
-
-
?
additional information
?
-
-
in human pyruvate dehydrogenase complex the pyruvate dehydrogenase (E1) is bound to the E1-binding domain of dihydrolipoamide acetyltransferase (E2)
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Alzheimer Disease
An immunochemical study of the pyruvate dehydrogenase deficit in Alzheimer's disease brain.
Autoimmune Diseases
Autoantibodies of primary biliary cirrhosis recognize dihydrolipoamide acetyltransferase and inhibit enzyme function.
Bile Duct Neoplasms
Molecular cloning, and characterization and expression of dihydrolipoamide acetyltransferase component of murine pyruvate dehydrogenase complex in bile duct cancer cells.
Hepatitis
Identification of the dihydrolipoamide acetyltransferase subunit of the human pyruvate dehydrogenase complex as an autoantigen in halothane hepatitis. Molecular mimicry of trifluoroacetyl-lysine by lipoic acid.
Liver Cirrhosis, Biliary
A lipoyl synthetic octadecapeptide of dihydrolipoamide acetyltransferase specifically recognized by anti-M2 autoantibodies in primary biliary cirrhosis.
Liver Cirrhosis, Biliary
Antibody to two forms of dihydrolipoamide acetyltransferase (PDC-E2) in primary biliary cirrhosis.
Liver Cirrhosis, Biliary
Antimitochondrial autoantibodies in primary biliary cirrhosis recognize cross-reactive epitope(s) on protein X and dihydrolipoamide acetyltransferase of pyruvate dehydrogenase complex.
Liver Cirrhosis, Biliary
Autoantibodies of primary biliary cirrhosis recognize dihydrolipoamide acetyltransferase and inhibit enzyme function.
Liver Cirrhosis, Biliary
Chromosome localization and RFLP analysis of PDC-E2: the major autoantigen of primary biliary cirrhosis.
Liver Cirrhosis, Biliary
Combinatorial autoantibodies to dihydrolipoamide acetyltransferase, the major autoantigen of primary biliary cirrhosis.
Liver Cirrhosis, Biliary
Distribution of dihydrolipoamide acetyltransferase (E2) in the liver and portal lymph nodes of patients with primary biliary cirrhosis: an immunohistochemical study.
Liver Cirrhosis, Biliary
Distribution of pyruvate dehydrogenase dihydrolipoamide acetyltransferase (PDC-E2) and another mitochondrial marker in salivary gland and biliary epithelium from patients with primary biliary cirrhosis.
Liver Cirrhosis, Biliary
Epitope mapping on E1alpha subunit of pyruvate dehydrogenase complex with autoantibodies of patients with primary biliary cirrhosis.
Liver Cirrhosis, Biliary
Immunization of experimental animals with dihydrolipoamide acetyltransferase, as a purified recombinant polypeptide, generates mitochondrial antibodies but not primary biliary cirrhosis.
Liver Cirrhosis, Biliary
Immunopathology of primary biliary cirrhosis.
Liver Cirrhosis, Biliary
Membrane dihydrolipoamide acetyltransferase (E2) on human biliary epithelial cells in primary biliary cirrhosis.
Liver Cirrhosis, Biliary
Molecular cloning, and characterization and expression of dihydrolipoamide acetyltransferase component of murine pyruvate dehydrogenase complex in bile duct cancer cells.
Liver Cirrhosis, Biliary
Natural and disease associated autoantibodies to the autoantigen, dihydrolipoamide acetyltransferase, recognise different epitopes.
Liver Cirrhosis, Biliary
Nucleotide sequence analysis of natural and combinatorial anti-PDC-E2 antibodies in patients with primary biliary cirrhosis. Recapitulating immune selection with molecular biology.
Liver Cirrhosis, Biliary
Primary structure of the human M2 mitochondrial autoantigen of primary biliary cirrhosis: dihydrolipoamide acetyltransferase.
Liver Cirrhosis, Biliary
Random phage mimotopes recognized by monoclonal antibodies against the pyruvate dehydrogenase complex-E2 (PDC-E2).
Liver Cirrhosis, Biliary
Reactivity of primary biliary cirrhosis sera with Escherichia coli dihydrolipoamide acetyltransferase (E2p): characterization of the main immunogenic region.
Liver Cirrhosis, Biliary
The autoepitope of the 74-kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase.
Liver Diseases
Immunization of experimental animals with dihydrolipoamide acetyltransferase, as a purified recombinant polypeptide, generates mitochondrial antibodies but not primary biliary cirrhosis.
Neoplasms
Molecular cloning, and characterization and expression of dihydrolipoamide acetyltransferase component of murine pyruvate dehydrogenase complex in bile duct cancer cells.
pyruvate dehydrogenase (nadp+) deficiency
Clinical and genetic spectrum of pyruvate dehydrogenase deficiency: dihydrolipoamide acetyltransferase (E2) deficiency.
pyruvate dehydrogenase (nadp+) deficiency
Partial complementation of pyruvate dehydrogenase deficiency by independently expressed lipoyl and catalytic domains of the dihydrolipoamide acetyltransferase component.
Pyruvate Dehydrogenase Complex Deficiency Disease
Clinical and genetic spectrum of pyruvate dehydrogenase deficiency: dihydrolipoamide acetyltransferase (E2) deficiency.
Pyruvate Dehydrogenase Complex Deficiency Disease
Partial complementation of pyruvate dehydrogenase deficiency by independently expressed lipoyl and catalytic domains of the dihydrolipoamide acetyltransferase component.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
polymer
-
60 * 42000, SDS-PAGE
trimer
-
3 * 82000, gel filtration, trimeric form occurs in solutions with 4 M guanidine hydrochloride
dimer
-
60mer, analytical ultracentrifugation
dimer
-
GST-L2, glutathione-S-transferase fused to the inner lipoyl domain (L2) of dihydrolipoyl acetyltransferase exists as a dimer
additional information
evidence for a novel subunit organization in which dihydrolipoamide dehydrogenase E3 and E3BP form subcomplexes with a 1:2 stoichiometry implying the existence of a network of dihydrolipoamide dehydrogenase cross-bridges linking pairs of E3-binding proteins across the surface of the dihydrolipoamide acetyltransferase E2 core assembly. One of the E3-binding protein lipoyl domains docks into the dihydrolipoamide dehydrogenase E3 active site
additional information
-
E2 is composed of 4 domains including the innerlipoyl domain L2 important for binding of E1
additional information
-
enzyme is a 60mer, E2 domain structure: 4 domains, i.e. L1, L2, B, and I domain, connected by linker oligomers, overview, overall multienzyme complex organization, overview
additional information
-
the enzyme forms the core unit E2, consisting of 4 domains in 60mer, a trimer of 3 20mers, of the pyruvate dehydrogenase multienzyme complex binding the other components, i.e. pyruvate decarboxylase and dihydrolipoyl dehydrogenase, tightly at its innerlipoyl or N-terminal lipoyl domain, respectively, composition overview
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
A174S
-
mutation in the inner lipoyl-bearing domain (L2), pyruvate dehydrogenase kinase 2 binding: 69%
D164A
-
mutation in the inner lipoyl-bearing domain (L2), pyruvate dehydrogenase kinase 2 binding: 55%
D172A
-
mutation in the inner lipoyl-bearing domain (L2), pyruvate dehydrogenase kinase 2 binding: 66%
E162A
-
mutation in the inner lipoyl-bearing domain (L2), pyruvate dehydrogenase kinase 2 binding: 93%
E179A
-
mutation in the inner lipoyl-bearing domain (L2), pyruvate dehydrogenase kinase 2 binding: 28%
E182Q
-
binding of mutant L2 domain to pyruvate dehydrogenase phosphatase isozyme 1 is hindered
E183A
-
mutation in the inner lipoyl-bearing domain (L2), pyruvate dehydrogenase kinase 2 binding: 98%
F231A
-
ability to be post-translationally lipoylated remains
I176A
-
mutation in the inner lipoyl-bearing domain (L2), pyruvate dehydrogenase kinase 2 binding: not measurable
I229A
-
ability to be post-translationally lipoylated remains
I229A/F231A
-
ability to be post-translationally lipoylated remains, far-UV CD spectrum differs from wild-type enzyme
K173A
-
mutation in the inner lipoyl-bearing domain (L2), pyruvate dehydrogenase kinase 2 binding: not measurable
K276A
-
mutant shows negligible binding to human pyruvate dehydrogenase with 86fold higher KD compared to wild-type
L140A
-
mutation in the inner lipoyl-bearing domain (L2), pyruvate dehydrogenase kinase 2 binding: not measurable
L189A
-
ability to be post-translationally lipoylated remains
M194A
-
ability to be post-translationally lipoylated remains
M197A
-
ability to be post-translationally lipoylated remains
R196A
-
mutation in the inner lipoyl-bearing domain (L2), pyruvate dehydrogenase kinase 2 binding: 79%
R297A
-
mutant is found to have KD 6.8fold higher than that for the wild-type, indicating a possible involvement of this residue in the interaction with human pyruvate dehydrogenase, but not with the C-terminal residue of beta-subunit
V180S/E181L
-
binding of mutant L2 domain to pyruvate dehydrogenase phosphatase isozyme 1 is hindered
V188A
-
ability to be post-translationally lipoylated remains, far-UV CD spectrum differs from wild-type enzyme
E182A
-
binding of mutant L2 domain to pyruvate dehydrogenase phosphatase isozyme 1 is hindered
E182A
-
mutation in the inner lipoyl-bearing domain (L2), pyruvate dehydrogenase kinase 2 binding: 100%
additional information
a truncated version of dihydrolipoyl acetyltransferase is created lacking the N-terminal 319 amino acids
additional information
-
a truncated version of dihydrolipoyl acetyltransferase is created lacking the N-terminal 319 amino acids
additional information
-
construction of diverse L2 domain mutants, e.g. substitutions of A172, D173, Leu140, Glu162, Glu181, and Glu179 highly reduce binding of L2 domain to pyruvate dehydrogenase phosphatase isozyme 1
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Thekkumkara, T.J.; Jesse, B.W.; Ho, L.; Raefsky, C.; Pepin, R.A.; Javed, A.A.; Pons, G.; Patel, M.S.
Isolation of a cDNA clone for the dihydrolipoamide acetyltransferase component of the human liver pyruvate dehydrogenase complex
Biochem. Biophys. Res. Commun.
145
903-907
1987
Homo sapiens
brenda
Jackson, J.C.; Vinluan, C.C.; Dragland, C.J.; Sundararajan, V.; Yan, B.; Gounarides, J.S.; Nirmala, N.R.; Topiol, S.; Ramage, P.; Blume, J.E.; Aicher, T.D.; Bell, P.A.; Mann, W.R.
Heterologously expressed inner lipoyl domain of dihydrolipoyl acetyltransferase inhibits ATP-dependent inactivation of pyruvate dehydrogenase complex, Identification of important amino acid residues
Biochem. J.
334
703-711
1998
Homo sapiens
-
brenda
McCartney, R.G.; Sanderson, S.J.; Lindsay, J.G.
Refolding and reconstitution studies on the transacetylase-protein X (E2/X) subcomplex of the mammalian pyruvate dehydrogenase complex: Evidence for specific binding of the dihydrolipoamide dehydrogenase component to sites on reassembled E2
Biochemistry
36
6819-6826
1997
Homo sapiens
brenda
Yang, D.; Song, J.; Wagenknecht, T.; Roche, T.E.
Assembly and full functionality of recombinantly expressed dihydrolipoyl acetyltransferase component of the human pyruvate dehydrogenase complex
J. Biol. Chem.
272
6361-6369
1997
Homo sapiens
brenda
Roche, T.E.; Hiromasa, Y.; Turkan, A.; Gong, X.; Peng, T.; Yan, X.; Kasten, S.A.; Bao, H.; Dong, J.
Essential roles of lipoyl domains in the activated function and control of pyruvate dehydrogenase kinases and phosphatase isoform 1
Eur. J. Biochem.
270
1050-1056
2003
Homo sapiens, Rattus norvegicus
brenda
Hiromasa, Y.; Roche, T.E.
Facilitated interaction between the pyruvate dehydrogenase kinase isoform 2 and the dihydrolipoyl acetyltransferase
J. Biol. Chem.
278
33681-33693
2003
Homo sapiens
brenda
Roche, T.E.; Hiromasa, Y.; Turkan, A.; Gong, X.; Peng, T.; Yan, X.; Kasten, S.A.; Bao, H.; Dong, J.
Central organization of mammalian pyruvate dehydrogenase (PD) complex and lipoyl domain-mediated activated function and control of PD kinases and phosphatase 1
Oxid. Stress Dis.
11
363-386
2004
Homo sapiens, Rattus norvegicus
-
brenda
Tuganova, A.; Klyuyeva, A.; Popov, K.M.
Recognition of the inner lipoyl-bearing domain of dihydrolipoyl transacetylase and of the blood glucose-lowering compound AZD7545 by pyruvate dehydrogenase kinase 2
Biochemistry
46
8592-8602
2007
Homo sapiens
brenda
Hiromasa, Y.; Hu, L.; Roche, T.E.
Ligand-induced effects on pyruvate dehydrogenase kinase isoform 2
J. Biol. Chem.
281
12568-12579
2006
Homo sapiens
brenda
Smolle, M.; Prior, A.E.; Brown, A.E.; Cooper, A.; Byron, O.; Lindsay, J.G.
A new level of architectural complexity in the human pyruvate dehydrogenase complex
J. Biol. Chem.
281
19772-19780
2006
Homo sapiens (P10515)
brenda
Korotchkina, L.G.; Patel, M.S.
Binding of pyruvate dehydrogenase to the core of the human pyruvate dehydrogenase complex
FEBS Lett.
582
468-472
2008
Homo sapiens
brenda
Yu, X.; Hiromasa, Y.; Tsen, H.; Stoops, J.K.; Roche, T.E.; Zhou, Z.H.
Structures of the human pyruvate dehydrogenase complex cores: a highly conserved catalytic center with flexible N-terminal domains
Structure
16
104-114
2008
Homo sapiens (P10515), Homo sapiens
brenda
Hiromasa, Y.; Yan, X.; Roche, T.E.
Specific ion influences on self-association of pyruvate dehydrogenase kinase isoform 2 (PDHK2), binding of PDHK2 to the L2 lipoyl domain, and effects of the lipoyl group-binding site inhibitor, Nov3r
Biochemistry
47
2312-2324
2008
Homo sapiens
brenda
Green, T.; Grigorian, A.; Klyuyeva, A.; Tuganova, A.; Luo, M.; Popov, K.
Structural and functional insights into the molecular mechanisms responsible for the regulation of pyruvate dehydrogenase kinase 2
J. Biol. Chem.
283
15789-15798
2008
Homo sapiens
brenda
Brautigam, C.A.; Wynn, R.M.; Chuang, J.L.; Chuang, D.T.
Subunit and catalytic component stoichiometries of an in vitro reconstituted human pyruvate dehydrogenase complex
J. Biol. Chem.
284
13086-13098
2009
Homo sapiens
brenda
Chen, R.; Xiao, M.; Gao, H.; Chen, Y.; Li, Y.; Liu, Y.; Zhang, N.
Identification of a novel mitochondrial interacting protein of C1QBP using subcellular fractionation coupled with CoIP-MS
Anal. Bioanal. Chem.
408
1557-1564
2016
Homo sapiens
brenda